Business● Low28m ago · Nov 13, 2026, 12:02 PM
Tvardi Therapeutics GAAP EPS of -$0.48 beats by $0.01
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Tvardi Therapeutics reported a GAAP EPS of -$0.48, which surpassed analyst expectations by $0.01, indicating the company's financial performance relative to forecasts. This matters for investors and stakeholders tracking the company's profitability.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business26m agoDollar today and blue dollar, LIVE: how much the official and parallel rates are trading this Friday, November 13, minute by minuteLa Nación · ArgentinaBusiness28m agoSingapore arrests five people for fraud related to Nvidia chipsInfobae · ArgentinaBusiness28m agoAustria: Hospitaller Brothers criticized over drug pricesTagesschau · GermanyBusiness31m agoSergipe cooperativism registers 181% growth in members since 2019G1 · Brazil